This wiki has undergone a migration to Confluence found Here
Difference between revisions of "January 2017 Pharmacy WGM Agenda"
Jump to navigation
Jump to search
(6 intermediate revisions by the same user not shown) | |||
Line 55: | Line 55: | ||
* Reps to other WGs | * Reps to other WGs | ||
** Do we need to send rep to EHR - ballot reconciliation for reaffirmation ballot | ** Do we need to send rep to EHR - ballot reconciliation for reaffirmation ballot | ||
− | **Monday Q2 - Future of V3 | + | **Monday Q2 - Future of V3 - Tom |
− | ** Monday Q3 - Structured Docs - Rep only | + | ** Monday Q3 - Structured Docs - Rep only - Scott |
***CDA Product Family - All work groups that have p developed or plan on developing CDA Related Standards/IG's are invited to send a representative to this meeting. There will be many work groups invited to participate, so send representatives only. | ***CDA Product Family - All work groups that have p developed or plan on developing CDA Related Standards/IG's are invited to send a representative to this meeting. There will be many work groups invited to participate, so send representatives only. | ||
** Tuesday Q2 - O&O - Rep only | ** Tuesday Q2 - O&O - Rep only | ||
− | ** Tuesday Q4 - PHER - Rep only | + | Action: check with Hans to see if there are any topics for discussion |
− | ** Thursday Q1 - Patient Care - Rep only | + | ** Tuesday Q4 - PHER - Rep only - will not send a rep, but John will follow-up with Joginder |
+ | ** Thursday Q1 - Patient Care - Rep only - Scott | ||
***Joint meeting with SD, Pharm, LHS, CH, FHIR-I Topics: All things care plan, care coordination, Care Team. | ***Joint meeting with SD, Pharm, LHS, CH, FHIR-I Topics: All things care plan, care coordination, Care Team. | ||
* Assign Roles for Quarters | * Assign Roles for Quarters | ||
Line 67: | Line 68: | ||
** Overview of Template work | ** Overview of Template work | ||
* Hot Topics | * Hot Topics | ||
− | * Approval of September 2016 WGM Minutes | + | * Approval of September 2016 WGM Minutes [http://www.hl7.org/documentcenter/public/wg/medication/minutes/HL7_Pharmacy_WG_Meeting_Minutes_-_Baltimore_September%202016_Final%20Draft.docx Sept 2016 Draft Minutes] |
− | ||Melva|| | + | ||Melva||Melva||TBD |
|- | |- | ||
||Q2||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||Q2||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||
* Prep for Clinicians on FHIR | * Prep for Clinicians on FHIR | ||
* FHIR Tracker Items (TBD) | * FHIR Tracker Items (TBD) | ||
− | * GF#12470 - [http://gforge.hl7.org/gf/project/fhir/tracker/?action=TrackerItemEdit&tracker_item_id=12470&start=0 TR12470] | + | ** GF#12470 - [http://gforge.hl7.org/gf/project/fhir/tracker/?action=TrackerItemEdit&tracker_item_id=12470&start=0 TR12470] |
− | * GF#7910 - [http://gforge.hl7.org/gf/project/fhir/tracker/?action=TrackerItemEdit&tracker_item_id=7910&start=0 TR7910] | + | ** GF#7910 - [http://gforge.hl7.org/gf/project/fhir/tracker/?action=TrackerItemEdit&tracker_item_id=7910&start=0 TR7910] |
** Discussion of whether we should create a DispenseRequest Type | ** Discussion of whether we should create a DispenseRequest Type | ||
**12340 Clarify guidance for substance use | **12340 Clarify guidance for substance use | ||
Line 84: | Line 85: | ||
** Knowledge Base Query - reaffirmation | ** Knowledge Base Query - reaffirmation | ||
** US Realm Profiles (Brett and Eric will join in second half of quarter) | ** US Realm Profiles (Brett and Eric will join in second half of quarter) | ||
− | ||Melva|| | + | ||Melva||John||TBD |
|- | |- | ||
| rowspan="2" align="middle" |PM | | rowspan="2" align="middle" |PM | ||
Line 106: | Line 107: | ||
***8489 Medication related indicators - maintenance drug, over the counter | ***8489 Medication related indicators - maintenance drug, over the counter | ||
***5827 Should medication have a status code? | ***5827 Should medication have a status code? | ||
− | || | + | ||John||Melva||TBD |
|- | |- | ||
||Q4||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||Q4||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||
Line 126: | Line 127: | ||
***8489 Medication related indicators - maintenance drug, over the counter | ***8489 Medication related indicators - maintenance drug, over the counter | ||
***5827 Should medication have a status code? | ***5827 Should medication have a status code? | ||
− | || | + | ||John||Melva||TBD |
|-border="4" cellpadding="8" style="background:#f0f0f0;" | |-border="4" cellpadding="8" style="background:#f0f0f0;" | ||
Line 153: | Line 154: | ||
***8489 Medication related indicators - maintenance drug, over the counter | ***8489 Medication related indicators - maintenance drug, over the counter | ||
***5827 Should medication have a status code? | ***5827 Should medication have a status code? | ||
− | || | + | ||John||Tom||TBD |
|- | |- | ||
||Q2||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||Q2||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||
Line 159: | Line 160: | ||
* Joint with FHIR Infrastructure | * Joint with FHIR Infrastructure | ||
* Topics TBD | * Topics TBD | ||
− | || | + | ||John||Tom||TBD |
|- | |- | ||
| rowspan="2" align="middle" |PM | | rowspan="2" align="middle" |PM | ||
||Q3||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||Q3||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||
* FHIR Tracker Items | * FHIR Tracker Items | ||
− | + | ||John||Scott||TBD | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | || | ||
|- | |- | ||
||Q4||[[Image:Technical_med.gif|24px]]||Joint with PHER (PHER hosting) | ||Q4||[[Image:Technical_med.gif|24px]]||Joint with PHER (PHER hosting) | ||
− | * | + | * Pharmacy will meet with PHER |
− | + | ||NA||NA||TBD | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | || | ||
|-border="4" cellpadding="8" style="background:#f0f0f0;" | |-border="4" cellpadding="8" style="background:#f0f0f0;" | ||
|. ||||||||||||||||| | |. ||||||||||||||||| | ||
Line 230: | Line 188: | ||
** 3 year plan review | ** 3 year plan review | ||
** Action Item list review | ** Action Item list review | ||
− | || | + | ||John||Melva||TBD |
|- | |- | ||
||Q2||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||Q2||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||
* Pharmacy Template Work (Kai) | * Pharmacy Template Work (Kai) | ||
− | ||Melva|| | + | ||Melva||John||TBD |
|- | |- | ||
| rowspan="2" align="middle" |PM | | rowspan="2" align="middle" |PM | ||
||Q3||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||Q3||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||
+ | * Discussion of what a snapshot of a patient's medication list is | ||
* FHIR Tracker Items | * FHIR Tracker Items | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
* Confirm with Brett if there are SD topics | * Confirm with Brett if there are SD topics | ||
− | ||Melva|| | + | ||Melva||Scott||TBD |
|- | |- | ||
||Q4||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||Q4||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||
Line 267: | Line 205: | ||
* Overview of Infoway MedicationRequest profiles and extensions (Jean Duteau) - 30 minutes | * Overview of Infoway MedicationRequest profiles and extensions (Jean Duteau) - 30 minutes | ||
* FHIR Tracker Items | * FHIR Tracker Items | ||
− | + | ||Scott||Melva||TBD | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | || | ||
|-border="4" cellpadding="8" style="background:#f0f0f0;" | |-border="4" cellpadding="8" style="background:#f0f0f0;" | ||
|. ||||||||||||||||| | |. ||||||||||||||||| | ||
Line 297: | Line 214: | ||
|rowspan="2" align="middle" |AM | |rowspan="2" align="middle" |AM | ||
||Q1||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||Q1||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||
− | * Rep to Patient Care | + | * Rep to Patient Care - Scott |
* Update from IHE Pharmacy (Michael Tan) | * Update from IHE Pharmacy (Michael Tan) | ||
+ | * General Session Pharmacy Presentation | ||
* FHIR Tracker Items | * FHIR Tracker Items | ||
− | + | ||Melva||John||TBD | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | ||Melva|| | ||
|- | |- | ||
||Q2||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||Q2||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||
* FHIR Tracker Items | * FHIR Tracker Items | ||
− | + | ||Scott||Melva||TBD | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | || | ||
|- | |- | ||
| rowspan="2" align="middle" |PM | | rowspan="2" align="middle" |PM | ||
||Q3||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||Q3||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||
* FHIR Tracker Items | * FHIR Tracker Items | ||
− | + | ||Scott||John||TBD | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | || | ||
|- | |- | ||
||Q4||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||Q4||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||
* FHIR Tracker Items | * FHIR Tracker Items | ||
− | + | ||Scott||John||TBD | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | || | ||
|-border="4" cellpadding="8" style="background:#f0f0f0;" | |-border="4" cellpadding="8" style="background:#f0f0f0;" | ||
|. ||||||||||||||||| | |. ||||||||||||||||| |
Latest revision as of 23:06, 16 January 2017
Contents |
Related Links |
Agenda
Day | Date | ' | Time | Icon | Event | Chair | Scribe | Room |
Sunday | January 15, 2017 | AM | Q1 | Pharmacy WG Not Meeting | NA | NA | NA | |
Q2 | Pharmacy WG Not Meeting | NA | NA | NA | ||||
PM | Q3 | Pharmacy WG Not Meeting | NA | NA | NA | |||
Q4 | Pharmacy WG Not Meeting | NA | NA | NA | ||||
. | ||||||||
Monday | January 16, 2017 | AM | Q1 | Committee Meeting
Action: check with Hans to see if there are any topics for discussion
|
Melva | Melva | TBD | |
Q2 | Committee Meeting
|
Melva | John | TBD | ||||
PM | Q3 | Committee Meeting
|
John | Melva | TBD | |||
Q4 | Committee Meeting
|
John | Melva | TBD | ||||
. | ||||||||
Tuesday | January 17, 2017 | AM | Q1 | Committee Meeting
|
John | Tom | TBD | |
Q2 | Committee Meeting
|
John | Tom | TBD | ||||
PM | Q3 | Committee Meeting
|
John | Scott | TBD | |||
Q4 | Joint with PHER (PHER hosting)
|
NA | NA | TBD | ||||
. | ||||||||
Wednesday | January 18, 2017 | AM | Q1 | Committee Meeting
|
John | Melva | TBD | |
Q2 | Committee Meeting
|
Melva | John | TBD | ||||
PM | Q3 | Committee Meeting
|
Melva | Scott | TBD | |||
Q4 | Committee Meeting
|
Scott | Melva | TBD | ||||
. | ||||||||
Thursday | January 19, 2017 | AM | Q1 | Committee Meeting
|
Melva | John | TBD | |
Q2 | Committee Meeting
|
Scott | Melva | TBD | ||||
PM | Q3 | Committee Meeting
|
Scott | John | TBD | |||
Q4 | Committee Meeting
|
Scott | John | TBD | ||||
. | ||||||||
Friday | January 20, 2017 | AM | Q1 | Pharmacy WG Not Meeting |
NA | NA | NA | |
Q2 | Pharmacy WG Not Meeting | NA | NA | NA | ||||
PM | Q3 | Pharmacy WG Not Meeting | NA | NA | NA | |||
Q4 | Pharmacy WG Not Meeting | NA | NA | NA | ||||
. |
Icons: